Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$543.48 - $670.97 $4.02 Million - $4.97 Million
7,400 Added 92.5%
15,400 $9.73 Million
Q3 2021

Nov 15, 2021

SELL
$574.03 - $680.96 $5.34 Million - $6.33 Million
-9,300 Reduced 53.76%
8,000 $4.84 Million
Q2 2021

Aug 16, 2021

SELL
$472.8 - $558.54 $520,080 - $614,394
-1,100 Reduced 5.98%
17,300 $9.66 Million
Q1 2021

May 17, 2021

SELL
$446.73 - $548.2 $804,114 - $986,760
-1,800 Reduced 8.91%
18,400 $8.71 Million
Q4 2020

Feb 16, 2021

BUY
$478.3 - $607.98 $6.5 Million - $8.27 Million
13,600 Added 206.06%
20,200 $9.76 Million
Q3 2020

Nov 16, 2020

BUY
$544.75 - $658.21 $3 Million - $3.62 Million
5,500 Added 500.0%
6,600 $3.7 Million
Q2 2020

Aug 14, 2020

SELL
$493.32 - $643.92 $3.21 Million - $4.19 Million
-6,500 Reduced 85.53%
1,100 $686,000
Q1 2020

May 15, 2020

SELL
$336.18 - $494.43 $3.7 Million - $5.44 Million
-11,000 Reduced 59.14%
7,600 $3.71 Million
Q4 2019

Feb 14, 2020

BUY
$274.13 - $376.51 $1.21 Million - $1.66 Million
4,400 Added 30.99%
18,600 $6.98 Million
Q3 2019

Nov 14, 2019

BUY
$273.46 - $318.39 $1.12 Million - $1.31 Million
4,100 Added 40.59%
14,200 $3.94 Million
Q2 2019

Aug 14, 2019

BUY
$299.6 - $414.82 $329,560 - $456,302
1,100 Added 12.22%
10,100 $3.16 Million
Q1 2019

May 15, 2019

BUY
$372.08 - $439.57 $2.98 Million - $3.52 Million
8,000 Added 800.0%
9,000 $3.7 Million
Q3 2018

Nov 14, 2018

BUY
$351.14 - $408.51 $351,140 - $408,510
1,000 New
1,000 $404,000
Q2 2018

Aug 14, 2018

SELL
$284.6 - $344.99 $6.83 Million - $8.28 Million
-24,000 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$315.82 - $393.78 $4.74 Million - $5.91 Million
15,000 Added 166.67%
24,000 $8.27 Million
Q4 2017

Feb 14, 2018

BUY
$358.63 - $469.95 $215,178 - $281,970
600 Added 7.14%
9,000 $3.38 Million
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $3.62 Million - $4.23 Million
8,400
8,400 $3.76 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.